What is the appropriate management of anaphylaxis induced by a skin prick test?

Management of Anaphylaxis Induced by Skin Prick Test

Immediately administer intramuscular epinephrine 0.01 mg/kg (maximum 0.3 mg in prepubertal children, 0.5 mg in teenagers/adults) into the mid-outer thigh (vastus lateralis) as soon as anaphylaxis is recognized—this is the only evidence-based first-line intervention and must not be delayed. 1, 2

Immediate First-Line Management

The cornerstone of treatment is epinephrine administered intramuscularly in the thigh, which provides more rapid absorption and higher plasma levels compared to subcutaneous or deltoid injection 1. This should occur within seconds of recognizing anaphylaxis, regardless of severity assessment.

Primary Intervention Steps:

1. Epinephrine IM immediately:

   • Adults/adolescents: 0.3-0.5 mg (0.3-0.5 mL of 1:1000 dilution)
   • Children: 0.01 mg/kg (maximum 0.3 mg)
   • Inject into vastus lateralis muscle
   • Repeat every 5 minutes as needed if inadequate response 1, 2

2. Position the patient: Place supine with legs elevated (unless respiratory distress/vomiting present) to prevent orthostatic hypotension and maintain cerebral/cardiac perfusion 1

3. Call for help: Activate emergency response immediately

Secondary Interventions (After Epinephrine)

These adjunctive measures should never delay or substitute for epinephrine 3:

Airway and Breathing:

• Assess and maintain airway patency
• Administer supplemental oxygen at 6-8 L/min 1
• Consider endotracheal intubation or cricothyrotomy if severe laryngeal edema (only if trained) 1
• For bronchospasm resistant to epinephrine: nebulized albuterol 2.5-5 mg in 3 mL saline, repeat as necessary 1

Circulation:

• Establish IV access with normal saline
• Aggressive fluid resuscitation:
  • Adults: 1-2 L at 5-10 mL/kg in first 5 minutes (up to 7 L may be needed due to 50% intravascular fluid shift within 10 minutes) 1
  • Children: up to 30 mL/kg in first hour 1

Adjunctive Medications (Second-Line Only):

H1-antihistamine: Diphenhydramine 1-2 mg/kg or 25-50 mg parenterally 1

H2-antihistamine: Ranitidine 1 mg/kg IV over 5 minutes (combination with H1-antihistamine is superior to H1 alone, but both are second-line to epinephrine) 1

Glucocorticoids: Consider only for patients with severe/prolonged anaphylaxis, history of asthma, or idiopathic anaphylaxis. Methylprednisolone 1-2 mg/kg/day IV every 6 hours (or prednisone 0.5 mg/kg PO for less critical episodes). Note: Not helpful acutely but may prevent biphasic reactions 1, 3

Refractory Anaphylaxis Management

If inadequate response to multiple IM epinephrine doses and fluid resuscitation:

Epinephrine infusion:

• Prepare 1 mg (1 mL of 1:1000) in 250 mL D5W = 4 mcg/mL
• Infuse at 1-4 mcg/min, titrate up to maximum 10 mcg/min
• Critical warning: IV epinephrine carries risk of lethal arrhythmias; reserve for cardiac arrest or profound hypotension unresponsive to IM doses and fluids 1

Vasopressor for refractory hypotension: Dopamine 400 mg in 500 mL D5W at 2-20 mcg/kg/min with continuous hemodynamic monitoring 1

For patients on β-blockers: Glucagon 1-5 mg IV over 5 minutes, then 5-15 mcg/min infusion (20-30 mcg/kg in children, max 1 mg). Monitor for nausea/vomiting 1

Observation and Follow-Up

Observation period must be individualized as there are no reliable predictors of biphasic reactions based on initial presentation 1. Risk factors for biphasic anaphylaxis include:

• Severe initial reaction
• Need for >1 dose of epinephrine
• History of asthma 3

Minimum observation: 4-6 hours for mild reactions, longer for severe reactions or those requiring multiple epinephrine doses

Post-Stabilization Actions:

• Document serum tryptase levels (acute and baseline) for diagnostic confirmation 4
• Prescribe epinephrine autoinjector with proper training
• Refer to allergist-immunologist for comprehensive evaluation 1
• Avoid future skin testing with the implicated allergen

Critical Pitfalls to Avoid

1. Never delay epinephrine for antihistamines or corticosteroids—these have slower onset and are ineffective as monotherapy 1, 3

2. Do not use IV epinephrine as first-line—IM route is safer and appropriate for initial management 1

3. Avoid subcutaneous epinephrine or deltoid injection—thigh IM provides superior pharmacokinetics 1

4. Do not allow patient to stand or walk—maintain supine position to prevent cardiovascular collapse 2

5. Never perform skin prick testing without immediate access to emergency equipment and epinephrine 5, 6, 7, 8

Context-Specific Considerations

Anaphylaxis from skin prick testing is rare (0.005-0.008% risk) but well-documented, particularly with prick-to-prick testing using fresh foods (especially nuts, fish, legumes) 5, 9, 6, 8. Risk factors include young age, concomitant asthma/atopic dermatitis, history of previous anaphylaxis, and use of multiple fresh allergens 5, 8. The management algorithm remains identical regardless of trigger—epinephrine first, everything else second 3, 10, 4.